Clinical trial

Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy

NCT03541551

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-07-13

PhaseNA

Study timeline

Study start (actual)2018-07-13Date precision: day

Registry last updated2022-04-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Primary Congenital Glaucomaunresolved

Developmental Glaucomaunresolved

Infantile Glaucomaunresolved

Interventions

CTT with ologen® Collagen MatrixPROCEDURE

Trab TrabPROCEDURE

Sponsors & collaborators

L.V. Prasad Eye Institutelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03541551 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.